TrialX
Image

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus

Recruiting
20-74 years
All
Phase 1

Overview

The main purpose of this study is to evaluate the safety of a study drug known as LY3209590 in Japanese participants with type 2 diabetes. Side effects and tolerability will be documented. Blood samples will be taken to compare how the body handles the drug and how it affects blood sugar levels. The study will last almost five months for each participant.

Eligibility

Inclusion Criteria:

  • Have type 2 diabetes mellitus (T2DM) for at least 1 year
  • Have received a stable daily dose of basal insulin at screening
  • Have hemoglobin A1c (HbA1c) greater than or equal to ()6.5 percent (%) and less than or equal to ()10.0% at screening
  • Have a body mass index greater than (>)18.5 and 40.0 kilograms per square meter (kg/m) at screening

Exclusion Criteria:

  • Have received a total daily dose of insulin >1.2 units per kilogram (U/kg) of body weight at screening
  • Have received insulins except for basal insulins
  • Have received sulfonylurea at more than half of the maximum approved dose level
  • Have a history of multiple and/or severe allergies to drugs or foods or a history of severe anaphylactic reaction or history of significant atopy
  • Have had more than 1 episode of severe hypoglycemia within 6 months before entry

Study details
    NIDDM

NCT04276428

Eli Lilly and Company

16 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.